Crystal structure of insulin receptor kinase domain in complex with cis-(r)-7-(3-(azetidin-1-ylmethyl)cyclobutyl)-5-(3-((tetrahydro-2h- pyran-2-yl)methoxy)phenyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine.
F.Stauffer
et al.
(2016).
Identification of a 5-[3-phenyl-(2-cyclic-ether)-methylether]-4-aminopyrrolo[2,3-d]pyrimidine series of IGF-1R inhibitors.
Bioorg Med Chem Lett,
26,
2065-2067.
PubMed id: 26951750
DOI: 10.1016/j.bmcl.2016.02.074
We report structure-guided modifications of the benzyloxy substituent of the
Insulin-like Growth Factor-1 Receptor (IGF-1R) inhibitor NVP-AEW541. This
chemical group has been shown to confer selectivity against other protein
kinases but at the expense of a metabolism liability. X-ray crystallography has
revealed that the benzyloxy moiety interacts with a lysine cation of the IGF-1R
kinase domain via its ether function and its aromatic π-system and is nicely
embedded in an induced hydrophobic pocket. We show that 1,4-diethers displaying
an adequate hydrophobic and constrained shape are advantageous benzyloxy
replacements. A single digit nanomolar inhibitor (compound 20, IC50=8.9nM) was
identified following this approach.